Abstract 1464: Telomere DNA damage links benign prostatic hypertrophy, intraepithelial neoplasia, and prostate cancer

2018 ◽  
Author(s):  
Jianchun Wu ◽  
David L. Crowe
Keyword(s):  
Prostate Cancer ◽  
Dna Damage ◽  
Benign Prostatic Hypertrophy ◽  
Intraepithelial Neoplasia ◽  
Prostatic Hypertrophy

Excretion of Three Major Prostatic Secretory Proteins in the Urine of Normal Men and Patients With Benign Prostatic Hypertrophy or Prostate Cancer

1987 ◽  
Vol 138 (6) ◽  
pp. 1482-1483
Author(s):  
J. Tremblay ◽  
G. Frenette ◽  
R.R. Tremblay ◽  
A. Dupont ◽  
M. Thabet ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Secretory Proteins ◽  
Normal Men

scholarly journals 224: Exposure to Sunlight in Men with Benign Prostatic Hypertrophy, Prostate Cancer and Basal Cell Carcinoma: Can Safe Patterns of Exposure be Defined?

2007 ◽  
Vol 177 (4S) ◽  
pp. 75-75
Author(s):  
Nicholas J. Rukin ◽  
Maurice P. Zeegers ◽  
Sudarshan Ramachandran ◽  
Chritopher J. Luscombe ◽  
Samson Liu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy

scholarly journals MP04-10 USE OF 5?-REDUCTASE INHIBITORS FOR BENIGN PROSTATIC HYPERTROPHY AND RISK OF HIGH-GRADE PROSTATE CANCER: A FRENCH POPULATION-BASED STUDY

2018 ◽  
Vol 199 (4S) ◽  
Author(s):  
Lucie-Marie SCAILTEUX ◽  
Frédéric BALUSSON ◽  
Emmanuel NOWAK ◽  
Sébastien VINCENDEAU ◽  
Nathalie RIOUX-LECLERCQ ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hypertrophy ◽  
Population Based ◽  
Prostatic Hypertrophy ◽  
High Grade ◽  
French Population ◽  
Population Based Study ◽  
Reductase Inhibitors

Incidence of Surgically Treated Benign Prostatic Hypertrophy and of Prostate Cancer among Blacks and Whites in a Prepaid Health Care Plan

1991 ◽  
Vol 134 (8) ◽  
pp. 825-829 ◽  
Author(s):  
Stephen Sidney ◽  
Charles P. Quesenberry ◽  
Marianne C Sadler ◽  
Harry A. Guess ◽  
Eva G. Lydick ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Health Care ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Care Plan ◽  
Health Care Plan ◽  
Blacks And Whites

Usefulness of PSA Density and PSA Excess in the Differential Diagnosis between Prostate Cancer and Benign Prostatic Hypertrophy

1996 ◽  
Vol 11 (1) ◽  
pp. 12-17 ◽  
Author(s):  
F. Diaz ◽  
M. Morell ◽  
G. Rojo
Keyword(s):  
Prostate Cancer ◽  
Cancer Diagnosis ◽  
Predictive Value ◽  
Prostatic Cancer ◽  
Digital Rectal Examination ◽  
Benign Prostatic Hypertrophy ◽  
Transitional Zone ◽  
Prostatic Hypertrophy ◽  
Diagnostic Efficacy ◽  
Psa Density

The usefulness of PSA density (PSAD) was evaluated in relation to the volume of the transitional zone (PSAT) and PSA excess. With this purpose we conducted a study including 27 patients diagnosed as having prostatic cancer (PC) and 46 patients with benign prostatic hypertrophy (BPH). In all of them, the PSA concentration in the serum was determined as well as the total prostatic volume and the transitional zone volume; digital rectal examination (DRE) was also performed. The major diagnostic efficacy was obtained with the excess of PSA (73%, cutoff = -13 ng/ml), followed by DRE (68%), PSAT (64%, cutoff = 0.5), PSAD (64%, cutoff = 0.2), and lastly PSA and ultrasonography (60%). Multivariate analysis (logistic regression) demonstrated PSA excess and DRE to be the best predictors. The model obtained by regression shows the best positive predictive value, and PSA excess the best negative predictive value. Consequently, PSA excess could be relevant in prostate cancer diagnosis.

Testosterone Levels in Benign Prostatic Hypertrophy and Prostate Cancer

2008 ◽  
Vol 80 (2) ◽  
pp. 134-140 ◽  
Author(s):  
Luigi Mearini ◽  
Elisabetta Costantini ◽  
Alessandro Zucchi ◽  
Ettore Mearini ◽  
Vittorio Bini ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Testosterone Levels
Sign in / Sign up

Export Citation Format

Share Document